Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker VNOM
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 10, 2026 | VNOM Viper Energy, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 2, 2026 | VNOM Viper Energy, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 16, 2026 | VNOM Viper Energy, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 8, 2026 | VNOM Viper Energy, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Aug 3, 2026 | VNOM Viper Energy, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 2, 2026 | VNOM Viper Energy, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 15, 2026 | VNOM Viper Energy, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 15, 2026 | VNOM Viper Energy, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 19, 2026 | VNOM Viper Energy, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 19, 2026 | VNOM Viper Energy, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| May 4, 2026 | VNOM Viper Energy, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 4, 2026 | VNOM Viper Energy, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 4, 2026 | VNOM Viper Energy, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 4, 2026 | VNOM Viper Energy, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 3, 2026 | VNOM Viper Energy, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 3, 2026 | VNOM Viper Energy, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 23, 2026 | VNOM Viper Energy, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 19, 2026 | VNOM Viper Energy, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 30, 2025 | VNOM Viper Energy, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 12, 2025 | VNOM Viper Energy, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 3, 2025 | VNOM Viper Energy, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
21 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances